Medicomp Mobile Cardiac Telemetry Company
Medicomp is has been a stable player in the ambulatory cardiac monitoring business for more than 33 years. Medicomp is known for designing and manufacturing reliable Holter Monitoring and Cardiac Event Monitoring devices and software. Medicomp announced the FDA approval of their proprietary SAVI Wireless Mobile Cardiac Telemetry (MCT) system in 2010.
Much like other Mobile Cardiac Telemetry device, the Medicomp SAVI Wireless Mobile Cardiac Telemetry device acquires 2 channel ECG information in real time for a period of up to 30 days. The SAVI Wireless Mobile Cardiac Telemetry device automatically detects, and automatically transmits abnormal ECG information via cellular technology to the Medicomp 24/7/365 Cardiac Monitoring Center for analysis and review by certified cardiac technicians.
Competitive Advantage in Mobile Cardiac Telemetry
Medicomp has developed their own patented ‘Diogenes’ algorithm for advanced & accurate detection of asymptomatic cardiac arrhythmias. The proprietary Medicomp ‘Diogenes’ ECG algorithm in the SAVI Wireless Mobile Cardiac Telemetry device is a distinct competitive advantage among other providers of Mobile Cardiac Telemetry technology. The ‘Diogenes’ is the only ECG algorithm that is FDA cleared to analyze heart rate, rhythm status, beat morphology, and measuring p-wave abnormalities. The sophistication & ability of this algorithm to automatically capture asymptomatic arrhythmias makes the SAVI Wireless an attractive option for those looking for Mobile Cardiac Telemetry technology.
Medicomp offers a full suite of ambulatory monitoring solutions with seamless integration to your electronic medical records system (EMR).
Medicomp is a Independent Diagnostic Testing Facility (IDTF) accredited with Centers for Medicare and Medicaid (CMS).
Legal & Safety Notice
Medicomp has a sound reputation for manufacturing and regulatory processes. To date, there is no public notice of any legal disputes with their technology. Medicomp may be the only MCT company to remain out of litigation with the big service companies such as LifeWatch and CardioNet.